These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

449 related articles for article (PubMed ID: 27791389)

  • 21. Measuring cognitive impairment in young adults with polysubstance use disorder with MoCA or BRIEF-A - The significance of psychiatric symptoms.
    Hagen E; Sømhovd M; Hesse M; Arnevik EA; Erga AH
    J Subst Abuse Treat; 2019 Feb; 97():21-27. PubMed ID: 30577896
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Validity of the Montreal Cognitive Assessment Screener in Adolescents and Young Adults With and Without Congenital Heart Disease.
    Pike NA; Poulsen MK; Woo MA
    Nurs Res; 2017; 66(3):222-230. PubMed ID: 28448372
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Screening for Mild Cognitive Impairment: Comparison of "MCI Specific" Screening Instruments.
    O'Caoimh R; Timmons S; Molloy DW
    J Alzheimers Dis; 2016; 51(2):619-29. PubMed ID: 26890758
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The Montreal Cognitive Assessment: Normative Data from a Large Swedish Population-Based Cohort.
    Borland E; Nägga K; Nilsson PM; Minthon L; Nilsson ED; Palmqvist S
    J Alzheimers Dis; 2017; 59(3):893-901. PubMed ID: 28697562
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Validation of the Montreal Cognitive Assessment (MoCA) in Spanish as a screening tool for mild cognitive impairment and mild dementia in patients over 65 years old in Bogotá, Colombia.
    Gil L; Ruiz de Sánchez C; Gil F; Romero SJ; Pretelt Burgos F
    Int J Geriatr Psychiatry; 2015 Jun; 30(6):655-62. PubMed ID: 25320026
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Improving screening for vascular cognitive impairment at three to six months after mild ischemic stroke and transient ischemic attack.
    Dong Y; Slavin MJ; Chan BP; Venketasubramanian N; Sharma VK; Collinson SL; Sachdev PS; Chen CL
    Int Psychogeriatr; 2014 May; 26(5):787-93. PubMed ID: 24423626
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The role of the Montreal Cognitive Assessment (MoCA) and its memory tasks for detecting mild cognitive impairment.
    Li X; Jia S; Zhou Z; Jin Y; Zhang X; Hou C; Zheng W; Rong P; Jiao J
    Neurol Sci; 2018 Jun; 39(6):1029-1034. PubMed ID: 29550982
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Screening for cognitive impairment with the Montreal Cognitive Assessment in Chinese patients with acute mild stroke and transient ischaemic attack: a validation study.
    Zuo L; Dong Y; Zhu R; Jin Z; Li Z; Wang Y; Zhao X; Sachdev P; Zhang W; Wang Y
    BMJ Open; 2016 Jul; 6(7):e011310. PubMed ID: 27406642
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Screening for cognitive impairment in systemic lupus erythematosus: Application of the Montreal Cognitive Assessment (MoCA) in a Greek patient sample.
    Papastefanakis E; Dimitraki G; Ktistaki G; Fanouriakis A; Karamaouna P; Bardos A; Kallitsakis I; Adamichou C; Gergianaki I; Repa A; Bertsias G; Sidiropoulos P; Karademas E; Simos P
    Lupus; 2021 Dec; 30(14):2237-2247. PubMed ID: 34861804
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of the Montreal Cognitive Assessment and the Mini-Mental State Examination in detecting multi-domain mild cognitive impairment in a Chinese sub-sample drawn from a population-based study.
    Dong Y; Yean Lee W; Hilal S; Saini M; Wong TY; Chen CL; Venketasubramanian N; Ikram MK
    Int Psychogeriatr; 2013 Nov; 25(11):1831-8. PubMed ID: 23870281
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparison of the effectiveness of the Montreal Cognitive Assessment 7.2 and the Mini-Mental State Examination in the detection of mild neurocognitive disorder in people over 60 years of age. Preliminary study.
    Sokołowska N; Sokołowski R; Polak-Szabela A; Mazur E; Podhorecka M; Kędziora-Kornatowska K
    Psychiatr Pol; 2018 Oct; 52(5):843-857. PubMed ID: 30584818
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Validation of a novel Montreal Cognitive Assessment scoring algorithm in non-demented Parkinson's disease patients.
    Sulzer P; Becker S; Maetzler W; Kalbe E; van Nueten L; Timmers M; Machetanz G; Streffer J; Salvadore G; Scholz E; Tkaczynska Z; Brockmann K; Berg D; Liepelt-Scarfone I
    J Neurol; 2018 Sep; 265(9):1976-1984. PubMed ID: 29936665
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of the montreal cognitive assessment and the mini-mental state examination as screening tests in hemodialysis patients without symptoms.
    Lee SH; Cho A; Min YK; Lee YK; Jung S
    Ren Fail; 2018 Nov; 40(1):323-330. PubMed ID: 29633885
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Psychometrics of the Montreal Cognitive Assessment (MoCA) and its subscales: validation of the Taiwanese version of the MoCA and an item response theory analysis.
    Tsai CF; Lee WJ; Wang SJ; Shia BC; Nasreddine Z; Fuh JL
    Int Psychogeriatr; 2012 Apr; 24(4):651-8. PubMed ID: 22152127
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Italians do it worse. Montreal Cognitive Assessment (MoCA) optimal cut-off scores for people with probable Alzheimer's disease and with probable cognitive impairment.
    Bosco A; Spano G; Caffò AO; Lopez A; Grattagliano I; Saracino G; Pinto K; Hoogeveen F; Lancioni GE
    Aging Clin Exp Res; 2017 Dec; 29(6):1113-1120. PubMed ID: 28155182
    [TBL] [Abstract][Full Text] [Related]  

  • 36. MACE versus MoCA: equivalence or superiority? Pragmatic diagnostic test accuracy study.
    Larner AJ
    Int Psychogeriatr; 2017 Jun; 29(6):931-937. PubMed ID: 28264749
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cognitive impairment in hemodialysis patients: Implementation of cut-off values for the Montreal Cognitive Assessment (MoCA)-test for feasible screening.
    Angermann S; Baumann M; Steubl D; Lorenz G; Hauser C; Suttmann Y; Reichelt AL; Satanovskij R; Sonntag F; Heemann U; Grimmer T; Schmaderer C
    PLoS One; 2017; 12(10):e0184589. PubMed ID: 29016605
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Validation of the Czech Montreal Cognitive Assessment for Mild Cognitive Impairment due to Alzheimer Disease and Czech Norms in 1,552 Elderly Persons.
    Bartos A; Fayette D
    Dement Geriatr Cogn Disord; 2018; 46(5-6):335-345. PubMed ID: 30513529
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Usability and Validity of a Battery of Computerised Cognitive Screening Tests for Detecting Cognitive Impairment.
    Scanlon L; O'Shea E; O'Caoimh R; Timmons S
    Gerontology; 2016; 62(2):247-52. PubMed ID: 26113397
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Use of the Montreal Cognitive Assessment (MoCA) in Latin America: a systematic review].
    Loureiro C; Garcia C; Adana L; Yacelga T; Rodriguez-Lorenzana A; Maruta C
    Rev Neurol; 2018 Jun; 66(12):397-408. PubMed ID: 29897607
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.